Global Topical Absorbable Hemostat Market Research Report 2021

1 Topical Absorbable Hemostat Market Overview

• 1.1 Product Overview and Scope of Topical Absorbable Hemostat
• 1.2 Topical Absorbable Hemostat Segment by Type
  • 1.2.1 Global Topical Absorbable Hemostat Sales Growth Rate Comparison by Type (2021-2027)
  • 1.2.2 Combination Hemostats – Pads
  • 1.2.3 Oxidized Regenerated Cellulose Based Hemostats
  • 1.2.4 Polysaccharide Based Hemostats
  • 1.2.5 Gelatin Based Hemostats
  • 1.2.6 Collagen Based Hemostats
  • 1.2.7 Others
• 1.3 Topical Absorbable Hemostat Segment by Application
  • 1.3.1 Topical Absorbable Hemostat Sales Comparison by Application: (2021-2027)
  • 1.3.2 Surgery
  • 1.3.3 First-aid
  • 1.3.4 Health Care
• 1.4 Global Topical Absorbable Hemostat Market Size Estimates and Forecasts
  • 1.4.1 Global Topical Absorbable Hemostat Revenue 2016-2027
  • 1.4.2 Global Topical Absorbable Hemostat Sales 2016-2027
  • 1.4.3 Topical Absorbable Hemostat Market Size by Region: 2016 Versus 2021 Versus 2027

2 Topical Absorbable Hemostat Market Competition by Manufacturers

• 2.1 Global Topical Absorbable Hemostat Sales Market Share by Manufacturers (2016-2021)
• 2.2 Global Topical Absorbable Hemostat Revenue Market Share by Manufacturers (2016-2021)
• 2.3 Global Topical Absorbable Hemostat Average Price by Manufacturers (2016-2021)
• 2.4 Manufacturers Topical Absorbable Hemostat Manufacturing Sites, Area Served, Product Type
• 2.5 Topical Absorbable Hemostat Market Competitive Situation and Trends
  • 2.5.1 Topical Absorbable Hemostat Market Concentration Rate
  • 2.5.2 The Global Top 5 and Top 10 Largest Topical Absorbable Hemostat Players Market Share by Revenue
  • 2.5.3 Global Topical Absorbable Hemostat Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Topical Absorbable Hemostat Retrospective Market Scenario by Region

• 3.1 Global Topical Absorbable Hemostat Retrospective Market Scenario in Revenue by Region: 2016-2021
• 3.2 Global Topical Absorbable Hemostat Retrospective Market Scenario in Sales by Region: 2016-2021
• 3.3 North America Topical Absorbable Hemostat Market Facts & Figures by Country
  • 3.3.1 North America Topical Absorbable Hemostat Sales by Country
  • 3.3.2 North America Topical Absorbable Hemostat Revenue by Country
  • 3.3.3 U.S.
  • 3.3.4 Canada
• 3.4 Europe Topical Absorbable Hemostat Market Facts & Figures by Country
  • 3.4.1 Europe Topical Absorbable Hemostat Sales by Country
  • 3.4.2 Europe Topical Absorbable Hemostat Revenue by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Topical Absorbable Hemostat Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Topical Absorbable Hemostat Sales by Region
  • 3.5.2 Asia Pacific Topical Absorbable Hemostat Revenue by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.5.12 Philippines
  • 3.5.13 Vietnam
• 3.6 Latin America Topical Absorbable Hemostat Market Facts & Figures by Country
  • 3.6.1 Latin America Topical Absorbable Hemostat Sales by Country
  • 3.6.2 Latin America Topical Absorbable Hemostat Revenue by Country
  • 3.6.3 Mexico
  • 3.6.4 Brazil
  • 3.6.5 Argentina
• 3.7 Middle East and Africa Topical Absorbable Hemostat Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Topical Absorbable Hemostat Sales by Country
  • 3.7.2 Middle East and Africa Topical Absorbable Hemostat Revenue by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 UAE

4 Global Topical Absorbable Hemostat Historic Market Analysis by Type

• 4.1 Global Topical Absorbable Hemostat Sales Market Share by Type (2016-2021)
• 4.2 Global Topical Absorbable Hemostat Revenue Market Share by Type (2016-2021)
• 4.3 Global Topical Absorbable Hemostat Price by Type (2016-2021)

5 Global Topical Absorbable Hemostat Historic Market Analysis by Application

• 5.1 Global Topical Absorbable Hemostat Sales Market Share by Application (2016-2021)
• 5.2 Global Topical Absorbable Hemostat Revenue Market Share by Application (2016-2021)
• 5.3 Global Topical Absorbable Hemostat Price by Application (2016-2021)

6 Key Companies Profiled

• 6.1 3-D Matrix Ltd
  • 6.1.1 3-D Matrix Ltd Corporation Information
  • 6.1.2 3-D Matrix Ltd Description and Business Overview
  • 6.1.3 3-D Matrix Ltd Topical Absorbable Hemostat Sales, Revenue and Gross Margin (2016-2021)
  • 6.1.4 3-D Matrix Ltd Product Portfolio
  • 6.1.5 3-D Matrix Ltd Recent Developments/Updates
• 6.2 Angiotech Pharmaceuticals Inc
  • 6.2.1 Angiotech Pharmaceuticals Inc Corporation Information
  • 6.2.2 Angiotech Pharmaceuticals Inc Description and Business Overview
  • 6.2.3 Angiotech Pharmaceuticals Inc Topical Absorbable Hemostat Sales, Revenue and Gross Margin (2016-2021)
  • 6.2.4 Angiotech Pharmaceuticals Inc Product Portfolio
  • 6.2.5 Angiotech Pharmaceuticals Inc Recent Developments/Updates
• 6.3 Anika Therapeutics Inc
  • 6.3.1 Anika Therapeutics Inc Corporation Information
  • 6.3.2 Anika Therapeutics Inc Description and Business Overview
  • 6.3.3 Anika Therapeutics Inc Topical Absorbable Hemostat Sales, Revenue and Gross Margin (2016-2021)
  • 6.3.4 Anika Therapeutics Inc Product Portfolio
  • 6.3.5 Anika Therapeutics Inc Recent Developments/Updates
• 6.4 APRUS Bio-Medical Innovations Pvt Ltd
  • 6.4.1 APRUS Bio-Medical Innovations Pvt Ltd Corporation Information
  • 6.4.2 APRUS Bio-Medical Innovations Pvt Ltd Description and Business Overview
  • 6.4.3 APRUS Bio-Medical Innovations Pvt Ltd Topical Absorbable Hemostat Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 APRUS Bio-Medical Innovations Pvt Ltd Product Portfolio
  • 6.4.5 APRUS Bio-Medical Innovations Pvt Ltd Recent Developments/Updates
• 6.5 Arch Therapeutics Inc
  • 6.5.1 Arch Therapeutics Inc Corporation Information
  • 6.5.2 Arch Therapeutics Inc Description and Business Overview
  • 6.5.3 Arch Therapeutics Inc Topical Absorbable Hemostat Sales, Revenue and Gross Margin (2016-2021)
  • 6.5.4 Arch Therapeutics Inc Product Portfolio
  • 6.5.5 Arch Therapeutics Inc Recent Developments/Updates
• 6.6 Baxter
  • 6.6.1 Baxter Corporation Information
  • 6.6.2 Baxter Description and Business Overview
  • 6.6.3 Baxter Topical Absorbable Hemostat Sales, Revenue and Gross Margin (2016-2021)
  • 6.6.4 Baxter Product Portfolio
  • 6.6.5 Baxter Recent Developments/Updates
• 6.7 C.R. Bard
  • 6.6.1 C.R. Bard Corporation Information
  • 6.6.2 C.R. Bard Description and Business Overview
  • 6.6.3 C.R. Bard Topical Absorbable Hemostat Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 C.R. Bard Product Portfolio
  • 6.7.5 C.R. Bard Recent Developments/Updates
• 6.8 Cellphire Inc
  • 6.8.1 Cellphire Inc Corporation Information
  • 6.8.2 Cellphire Inc Description and Business Overview
  • 6.8.3 Cellphire Inc Topical Absorbable Hemostat Sales, Revenue and Gross Margin (2016-2021)
  • 6.8.4 Cellphire Inc Product Portfolio
  • 6.8.5 Cellphire Inc Recent Developments/Updates
• 6.9 Covalon Technologies Ltd
  • 6.9.1 Covalon Technologies Ltd Corporation Information
  • 6.9.2 Covalon Technologies Ltd Description and Business Overview
  • 6.9.3 Covalon Technologies Ltd Topical Absorbable Hemostat Sales, Revenue and Gross Margin (2016-2021)
  • 6.9.4 Covalon Technologies Ltd Product Portfolio
  • 6.9.5 Covalon Technologies Ltd Recent Developments/Updates
• 6.10 Cresilon Inc
  • 6.10.1 Cresilon Inc Corporation Information
  • 6.10.2 Cresilon Inc Description and Business Overview
  • 6.10.3 Cresilon Inc Topical Absorbable Hemostat Sales, Revenue and Gross Margin (2016-2021)
  • 6.10.4 Cresilon Inc Product Portfolio
  • 6.10.5 Cresilon Inc Recent Developments/Updates
• 6.11 Endomedix Incorporated
  • 6.11.1 Endomedix Incorporated Corporation Information
  • 6.11.2 Endomedix Incorporated Topical Absorbable Hemostat Description and Business Overview
  • 6.11.3 Endomedix Incorporated Topical Absorbable Hemostat Sales, Revenue and Gross Margin (2016-2021)
  • 6.11.4 Endomedix Incorporated Product Portfolio
  • 6.11.5 Endomedix Incorporated Recent Developments/Updates
• 6.12 Entegrion Inc
  • 6.12.1 Entegrion Inc Corporation Information
  • 6.12.2 Entegrion Inc Topical Absorbable Hemostat Description and Business Overview
  • 6.12.3 Entegrion Inc Topical Absorbable Hemostat Sales, Revenue and Gross Margin (2016-2021)
  • 6.12.4 Entegrion Inc Product Portfolio
  • 6.12.5 Entegrion Inc Recent Developments/Updates
• 6.13 Ethicon
  • 6.13.1 Ethicon Corporation Information
  • 6.13.2 Ethicon Topical Absorbable Hemostat Description and Business Overview
  • 6.13.3 Ethicon Topical Absorbable Hemostat Sales, Revenue and Gross Margin (2016-2021)
  • 6.13.4 Ethicon Product Portfolio
  • 6.13.5 Ethicon Recent Developments/Updates
• 6.14 ETX Pharma Inc
  • 6.14.1 ETX Pharma Inc Corporation Information
  • 6.14.2 ETX Pharma Inc Topical Absorbable Hemostat Description and Business Overview
  • 6.14.3 ETX Pharma Inc Topical Absorbable Hemostat Sales, Revenue and Gross Margin (2016-2021)
  • 6.14.4 ETX Pharma Inc Product Portfolio
  • 6.14.5 ETX Pharma Inc Recent Developments/Updates
• 6.15 Gelita
  • 6.15.1 Gelita Corporation Information
  • 6.15.2 Gelita Topical Absorbable Hemostat Description and Business Overview
  • 6.15.3 Gelita Topical Absorbable Hemostat Sales, Revenue and Gross Margin (2016-2021)
  • 6.15.4 Gelita Product Portfolio
  • 6.15.5 Gelita Recent Developments/Updates
• 6.16 Pfizer
  • 6.16.1 Pfizer Corporation Information
  • 6.16.2 Pfizer Topical Absorbable Hemostat Description and Business Overview
  • 6.16.3 Pfizer Topical Absorbable Hemostat Sales, Revenue and Gross Margin (2016-2021)
  • 6.16.4 Pfizer Product Portfolio
  • 6.16.5 Pfizer Recent Developments/Updates

7 Topical Absorbable Hemostat Manufacturing Cost Analysis

• 7.1 Topical Absorbable Hemostat Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Topical Absorbable Hemostat
• 7.4 Topical Absorbable Hemostat Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Topical Absorbable Hemostat Distributors List
• 8.3 Topical Absorbable Hemostat Customers

9 Topical Absorbable Hemostat Market Dynamics

• 9.1 Topical Absorbable Hemostat Industry Trends
• 9.2 Topical Absorbable Hemostat Growth Drivers
• 9.3 Topical Absorbable Hemostat Market Challenges
• 9.4 Topical Absorbable Hemostat Market Restraints

10 Global Market Forecast

• 10.1 Topical Absorbable Hemostat Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Topical Absorbable Hemostat by Type (2022-2027)
  • 10.1.2 Global Forecasted Revenue of Topical Absorbable Hemostat by Type (2022-2027)
• 10.2 Topical Absorbable Hemostat Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Topical Absorbable Hemostat by Application (2022-2027)
  • 10.2.2 Global Forecasted Revenue of Topical Absorbable Hemostat by Application (2022-2027)
• 10.3 Topical Absorbable Hemostat Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Topical Absorbable Hemostat by Region (2022-2027)
  • 10.3.2 Global Forecasted Revenue of Topical Absorbable Hemostat by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List